Our Mission
We are a specialized analytic firm with a focus in biotechnology. In order to screen and identify top investment companies, we bring exclusive expertise from scientists involved in cutting-edge research, and combine with decades of investment experience in the broader markets on Wall street.
We publish our research pieces periodically. The publication states the fundamental thesis on the investment opportunity regarding specific companies. It will offer in-depth analysis on their current developments, underlying scientific mechanisms of their leading drugs or drug candidates, as well as the potentials and challenges.
In addition, we offer our service to analyze a specific company upon request.
Areas of Expertise
Alzheimer’s Disease
The amyloid hypothesis for Alzheimer’s disease has led to countless failures in clinical trials from companies large and small in the last twenty plus years. However, there is a new entrant in this challenging field that carries great potential. Read more…
Oncology
Our panel of experts are mostly conducting research in elucidating the etiology of cancer.
Neurodegeneration
Our focus is on the inherent causes.